Himadri Speciality Chemical Allotment of Equity Shares on Warrant Exercise

Himadri Speciality Chemical Ltd has allotted 1,00,17,200 equity shares following the exercise of warrants, priced at ₹316 each. This allotment, approved on November 7, 2025, raised ₹237.40 crore. Consequently, the company’s issued and paid-up capital has increased to ₹50,44,94,950, consisting of 50,44,94,950 equity shares at ₹1 each. The new shares rank equally with existing shares.

Warrant Exercise and Equity Share Allotment

Himadri Speciality Chemical Ltd announced the allotment of 1,00,17,200 equity shares, each with a face value of ₹1. This allotment results from the exercise of warrants, initially allotted on May 14, 2024. The issue price for each warrant was ₹316, which included both the subscription and exercise price.

Financial Details of the Allotment

The company received a total of ₹237.40 crore from the warrant holders at a rate of ₹237 per warrant, representing 75% of the warrant issue price. This led to the allotment of new equity shares, as approved by the Share Issue & Allotment Committee on November 7, 2025.

Impact on Capital Structure

Following this allotment, the issued and paid-up capital of Himadri Speciality Chemical Ltd has increased to ₹50,44,94,950. This comprises 50,44,94,950 equity shares, each with a face value of ₹1. The newly allotted equity shares hold the same rights and privileges as the existing shares of the company.

Details of Allottees

The allotment included both promoters and non-promoters. Anurag Choudhary and Amit Choudhary were allotted 60,00,000 and 40,00,000 equity shares, respectively. Aditya Paresh Trivedi, a non-promoter, received an allotment of 17,200 shares.

Source: BSE

InvestyWise News
InvestyWise News
Covers market-moving news with speed and precision, delivering sharp insights to help readers stay ahead in the fast-paced world of stocks.

Latest articles

Related articles

Leave a reply

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!